ANDA 75894, held by Heritage Pharma. Fluvoxamine Maleate.
As of Nov 16, 2026, ANDA 75894 (Fluvoxamine Maleate), held by Heritage Pharma, was first approved by FDA on Apr 18, 2001, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 18, 2001 | Original application | Approved |
| Fluvoxamine Maleate25MG · tablet;oral | Fluvoxamine Maleate | Discontinued |
| Fluvoxamine Maleate50MG · tablet;oral | Fluvoxamine Maleate | Discontinued |
| Fluvoxamine Maleate100MG · tablet;oral | Fluvoxamine Maleate | Discontinued |
| Aug 18, 2023 | Supplement 2Labeling · Standard review | Approved | None posted |
| Apr 18, 2001 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters